.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Accenture
Federal Trade Commission
Dow
Harvard Business School
Fish and Richardson
QuintilesIMS
Daiichi Sankyo
Boehringer Ingelheim
Queensland Health

Generated: November 21, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020237

« Back to Dashboard
NDA 020237 describes SALAGEN, which is a drug marketed by Eisai Inc and is included in one NDA. It is available from four suppliers. Additional details are available on the SALAGEN profile page.

The generic ingredient in SALAGEN is pilocarpine hydrochloride. There are twelve drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the pilocarpine hydrochloride profile page.

Summary for 020237

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Dental and Oral Agents
Ophthalmic Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 020237

Suppliers and Packaging for NDA: 020237

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SALAGEN
pilocarpine hydrochloride
TABLET;ORAL 020237 NDA AUTHORIZED GENERIC Actavis Pharma, Inc. 0228-2801 0228-2801-11 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0228-2801-11)
SALAGEN
pilocarpine hydrochloride
TABLET;ORAL 020237 NDA AUTHORIZED GENERIC Actavis Pharma, Inc. 0228-2837 0228-2837-11 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0228-2837-11)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:Mar 22, 1994TE:ABRLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength7.5MG
Approval Date:Apr 18, 2003TE:ABRLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Queensland Health
Colorcon
Medtronic
Express Scripts
Julphar
UBS
Cerilliant
Fish and Richardson
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot